Search Results - "Milowsky MI"

Surveillance of urothelial carcinoma : stage and grade migration, 1993-2005 and survival trends, 1993-2000.

Authors: David KA Mallin K Milowsky MI et al.

Source: Cancer (0008543X). 4/1/2009, Vol. 115 Issue 7, p1435-1447. 13p.

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.

Authors: Vickers AJ Cronin AM Kattan MW et al.

Source: Cancer (0008543X). 12/1/2009, Vol. 115 Issue 23, p5460-5469. 10p.

Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on ¹⁸F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.

Authors: Islam MZ Perk TG Weisman A et al.

Source: Tomography (Ann Arbor, Mich.) [Tomography] 2026 Mar 11; Vol. 12 (3). Date of Electronic Publication: 2026 Mar 11.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101671170 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-139X (Electronic) Linking ISSN: 23791381 NLM ISO Abbreviation: Tomography Subsets: MEDLINE

Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study.

Authors: Jiang CY Hwang H Epstein IY et al.

Source: The oncologist [Oncologist] 2025 Nov 11; Vol. 30 (11).

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

EV-103 dose escalation/cohort A: 5-year follow-up of enfortumab vedotin plus pembrolizumab in previously untreated locally advanced/metastatic urothelial carcinoma.

Authors: Rosenberg JE O'Donnell PH Petrylak DP et al.

Source: ESMO open [ESMO Open] 2026 Jun; Vol. 11 (6), pp. 107700. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial.

Authors: Economides MP O'Donnell PH Alva AS et al.

Source: European urology [Eur Urol] 2026 Apr 06. Date of Electronic Publication: 2026 Apr 06.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.

Authors: Galsky MD Mantia C Bowden M et al.

Source: Nature medicine [Nat Med] 2026 Apr; Vol. 32 (4), pp. 1249-1256. Date of Electronic Publication: 2026 Feb 28.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Impact of Renal Mass Biopsy on Decision-Making Experience for Clinical T1 Renal Masses.

Authors: Gessner KH Deal AM Feinberg A et al.

Source: The Journal of urology [J Urol] 2026 Mar; Vol. 215 (3), pp. 316-325. Date of Electronic Publication: 2025 Oct 28.

Publication Type: Journal Article; Comparative Study; Clinical Trial

Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 0376374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3792 (Electronic) Linking ISSN: 00225347 NLM ISO Abbreviation: J Urol Subsets: MEDLINE

Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.

Authors: Galsky MD Gschwend JE Milowsky MI et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Jan; Vol. 37 (1), pp. 69-78. Date of Electronic Publication: 2025 Oct 17.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.

Authors: Sturdivant MS Truong AS Zhou M et al.

Source: Nature communications [Nat Commun] 2025 Dec 14; Vol. 17 (1), pp. 334. Date of Electronic Publication: 2025 Dec 14.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer.

Authors: Kailavasan M Martini A Bruins M et al.

Source: European urology focus [Eur Urol Focus] 2025 Nov; Vol. 11 (6), pp. 968-977. Date of Electronic Publication: 2025 Jun 09.

Publication Type: Journal Article; Systematic Review; Meta-Analysis

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101665661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-4569 (Electronic) Linking ISSN: 24054569 NLM ISO Abbreviation: Eur Urol Focus Subsets: MEDLINE

Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Authors: Nizam A Nguyen CB Li J et al.

Source: Cancer medicine [Cancer Med] 2025 Oct; Vol. 14 (19), pp. e71284.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instruments.

Authors: Kay H Rose TL Milowsky MI et al.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Sep; Vol. 31 (9), pp. 1061-1062. Date of Electronic Publication: 2024 May 29.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.

Authors: El Saadany T Lorch A Milowsky MI et al.

Source: Frontiers in oncology [Front Oncol] 2024 Aug 30; Vol. 14, pp. 1427452. Date of Electronic Publication: 2024 Aug 30 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer.

Authors: Beckabir W Zhou M Lee JS et al.

Source: Nature communications [Nat Commun] 2024 May 24; Vol. 15 (1), pp. 4448. Date of Electronic Publication: 2024 May 24.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.

Authors: Miller EJ Rose TL Maughan BL et al.

Source: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1642-1649. Date of Electronic Publication: 2024 Jan 05.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer.

Authors: Brower B McCoy A Ahmad H et al.

Source: Frontiers in oncology [Front Oncol] 2024 Apr 22; Vol. 14, pp. 1326715. Date of Electronic Publication: 2024 Apr 22 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study.

Authors: Jindal T Jiang CY Alhalabi O et al.

Source: European urology [Eur Urol] 2025 Sep 14. Date of Electronic Publication: 2025 Sep 14.

Publication Type: Letter

Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.

Authors: El Zarif T Nassar AH Pond GR et al.

Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Dec 06; Vol. 115 (12), pp. 1605-1615.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium.

Authors: Fahey CC Clark-Garvey S Porten S et al.

Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2025 May 14; Vol. 32 (5). Date of Electronic Publication: 2025 May 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE